Gil Y. Melmed, MD

Director, Inflammatory Bowel Disease Clinical Research

Co-Director, Clinical Inflammatory Bowel Disease

Gil Y. Melmed, MD

Steven Spielberg Building
8723 Alden Dr
Los AngelesCA





Gil Y. Melmed, MD

Director, Inflammatory Bowel Disease Clinical Research

Co-Director, Clinical Inflammatory Bowel Disease

  • IM/Gastroenterology
  • Inflammatory Bowel Disease

The research of Gil Melmed, MD, focuses on clinical outcomes research in inflammatory bowel disease. Specifically, he is interested in improving health outcomes, health-related quality of life, and quality of care. His research includes the role of vaccination in preventing infection, IBD disease phenotype and classification, and outcomes after surgery. Dr. Melmed oversees clinical trials of novel agents for Crohn's disease and ulcerative colitis.

View NIH Biographical Sketch as a PDF

  • Medical School: Albert Einstein College of Medicine, New York, 2000
  • Residency: Cedars-Sinai Medical Center, 2003
  • Master's: UCLA, 2006

View CV as a PDF

  • Invited Speaker, "Predicting Response to Biologic Therapies", Japanese Digestive Disease Week, Osaka, Japan, 2018
  • Invited Speaker, "Quality of Care in Inflammatory Bowel Disease", Asian American Association, Beijing, China, 2017
  • Visiting Professor, "Quality Improvement in Inflammatory Bowel Disease", University of Chicago, 2017
  • Associate Editor, American Journal of Gastroenterology, 2015-18
  • Chair, IBD Section of Quality Measures Committee, American Gastroenterology Association, 2014-15

Click here for a list of peer-reviewed publications.

  • Melmed GY, Dubinsky MC, Rubin DT, Fleisher M, Pasha SF, Sakuraba A, Tiongco F, Shafran I, Fernandez-Urien I, Rosa B, et al. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study. Gastrointest Endosc. 2018 Aug 4.
  • Winthrop KL, Melmed GY, Vermeire S, Long MD, Chan G, Pedersen RD, Lawendy N, Thorpe AJ, Nduaka CI, Su C. Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis. 2018 Sep 15.
  • Melmed GY, Kaplan GG, Sparrow MP, Velayos FS, Baidoo L, Bressler B, Cheifetz AS, Devlin SM, Irving PM, Jones J, et al. Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All. Clin Gastroenterol Hepatol. 2018 Mar 2.


Make an Appointment




Available 24 Hours A Day


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.